Your browser doesn't support javascript.
Structures of SARS-CoV-2 B.1.351 neutralizing antibodies provide insights into cocktail design against concerning variants.
Du, Shuo; Liu, Pulan; Zhang, Zhiying; Xiao, Tianhe; Yasimayi, Ayijiang; Huang, Weijin; Wang, Youchun; Cao, Yunlong; Xie, Xiaoliang Sunney; Xiao, Junyu.
  • Du S; State Key Laboratory of Protein and Plant Gene Research, Peking University, Beijing, China.
  • Liu P; School of Life Sciences, Peking University, Beijing, China.
  • Zhang Z; State Key Laboratory of Protein and Plant Gene Research, Peking University, Beijing, China.
  • Xiao T; School of Life Sciences, Peking University, Beijing, China.
  • Yasimayi A; State Key Laboratory of Protein and Plant Gene Research, Peking University, Beijing, China.
  • Huang W; School of Life Sciences, Peking University, Beijing, China.
  • Wang Y; School of Life Sciences, Peking University, Beijing, China.
  • Cao Y; Beijing Advanced Innovation Center for Genomics (ICG), Peking University, Beijing, China.
  • Xie XS; Biomedical Pioneering Innovation Center (BIOPIC), Peking University, Beijing, China.
  • Xiao J; School of Life Sciences, Peking University, Beijing, China.
Cell Res ; 31(10): 1130-1133, 2021 10.
Article in English | MEDLINE | ID: covidwho-1541181
Preprint
This scientific journal article is probably based on a previously available preprint. It has been identified through a machine matching algorithm, human confirmation is still pending.
See preprint
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antibodies, Neutralizing / Spike Glycoprotein, Coronavirus / SARS-CoV-2 Topics: Variants Limits: Humans Language: English Journal: Cell Res Year: 2021 Document Type: Article Affiliation country: S41422-021-00555-0

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antibodies, Neutralizing / Spike Glycoprotein, Coronavirus / SARS-CoV-2 Topics: Variants Limits: Humans Language: English Journal: Cell Res Year: 2021 Document Type: Article Affiliation country: S41422-021-00555-0